SEC Form 4 · accession 0001179110-18-007430
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Ortenzio
Officer — Exec. Chairman and Co-Founder · Director
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 21, 2018 | S | 85,740 | $18.57 | D | 7,086,480 | D | |
| Common StockF3 | May 22, 2018 | S | 59,553 | $18.53 | D | 7,026,927 | D | |
| Common StockF4 | May 23, 2018 | S | 2,920 | $18.52 | D | 7,024,007 | D | |
| Common StockF5 | holding | — | — | — | 800,000 | I | By the Robert A. Ortenzio July 2017 GRAT | |
| Common StockF5 | holding | — | — | — | 31,886 | I | By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio | |
| Common StockF5 | holding | — | — | — | 31,886 | I | By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio | |
| Common StockF5 | holding | — | — | — | 31,885 | I | By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio | |
| Common StockF5 | holding | — | — | — | 2,750,000 | I | By the Rocco A. Ortenzio Descendants Trust | |
| Common StockF5 | holding | — | — | — | 1,300,000 | I | By the Robert A. Ortenzio Descendants Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.70, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.63, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.55, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F5The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership to the reported securities except to the extent of his pecuniary interest therein.